Analysis for AME
- 📈 Growth — 24/30
- 💰 Profitability — 18/20
- 🏦 Financial Health — 16/20
- 💵 Valuation — 14/20
- ⚠️ Risk — 4/10
Summary:
📈 Growth & Financial Trajectory
Over the 8 quarters, AMETEK's revenues climb from approximately $1.71B in 2024-Q3 to about $2.04B in 2026-Q2, a ~33% rise. Net income grows from about $340M to around $407M, with a dip in 2025-Q4 before resuming strength, indicating an overall positive trajectory and improving operating leverage.
💰 Margins & Cash Flow
Gross margin sits in the mid-30s to high-30s percent (roughly 35-39%), supported by a stable product mix. Operating leverage remains favorable as volumes advance, while SG&A as a % of sales stays contained. Net operating cash flow is robust across quarters, and net cash flow turns positive in most periods, with investing cash flow typically negative due to capex and intangibles.
🛡️ Balance Sheet & Liquidity
Assets consistently exceed liabilities, with manageable debt levels (long-term debt around the low- to mid-$2B range) and steady equity base, supporting liquidity. Positive free cash flow in several quarters enhances resilience and capacity to fund dividends.
⚠️ Key Drivers & Risks
- Drivers: Broad industrial demand and diversified end-markets; stable pricing and cost discipline support margins.
- Risks: Cyclicality in industrial demand; potential volatility in quarterly earnings and sensitivity to macro conditions.